Instadose Competitors

INSD Stock  USD 0.0001  0.00  0.00%   
Analyzing Instadose Pharma competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Instadose Pharma to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Instadose Pharma Correlation with its peers.

Instadose Pharma vs Lords Company Correlation

No risk reduction

The correlation between Instadose Pharma Corp and LRDSF is 1.0 (i.e., No risk reduction) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Instadose Pharma Corp and LRDSF in the same portfolio, assuming nothing else is changed.
At present, Instadose Pharma's Return On Equity is projected to slightly grow based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 623.27, whereas Net Tangible Assets are projected to grow to (138.8 K).
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Instadose Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.0000840.00
Details

Instadose Pharma Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Instadose Pharma and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Instadose and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Instadose Pharma Corp does not affect the price movement of the other competitor.

High positive correlations

BIOIFISOLF
NUNZISOLF
MHTXISOLF
LRDSFISOLF
NUNZBIOIF
MHTXBIOIF
  

High negative correlations

QEBRCBGL
LRDSFQEBR
MHTXQEBR
LRDSFHENC
MHTXHENC
QEBRNUNZ

Risk-Adjusted Indicators

There is a big difference between Instadose Stock performing well and Instadose Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Instadose Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
OWCP  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
CBGL  11.85  2.26  0.00  23.79  0.00 
 100.00 
 150.00 
ISOLF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
ATTBF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
BIOIF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
NUNZ  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
HENC  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
QEBR  20.28  7.50  0.00  3.13  0.00 
 100.00 
 375.00 
MHTX  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
LRDSF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 

Instadose Pharma Competitive Analysis

The better you understand Instadose Pharma competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Instadose Pharma's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Instadose Pharma's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
INSD CBGL ISOLF BIOIF NUNZ HENC QEBR MHTX LRDSF
 0.00 
 0.0001 
Instadose
 0.00 
 0.0001 
Cannabis
 0.00 
 0.0001 
Isodiol
 0.00 
 0.0005 
Biome
 0.00 
 0.0001 
Nunzia
 0.00 
 0.0001 
Holloman
 0.00 
 0.0002 
Virtual
 0.00 
 0.0001 
Manhattan
 0.00 
 0.0002 
Lords
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Current Valuation
Price To Book
Operating Margin
Retained Earnings
Current Asset
One Year Return
Beta
Equity Positions Weight
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Total Debt
Return On Equity
Z Score
Return On Asset
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Target Price
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Year To Date Return
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Daily Balance Of Power
Day Typical Price
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Information Ratio
Value At Risk

Instadose Pharma Competition Performance Charts

Five steps to successful analysis of Instadose Pharma Competition

Instadose Pharma's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Instadose Pharma Corp in relation to its competition. Instadose Pharma's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Instadose Pharma in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Instadose Pharma's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Instadose Pharma Corp, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Instadose Pharma position

In addition to having Instadose Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Convertibles Funds Thematic Idea Now

Convertibles Funds
Convertibles Funds Theme
Funds or Etfs that invest in debt that is expected to be converted into a predetermined amount of the company equity at some future date. The Convertibles Funds theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Convertibles Funds Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Instadose Pharma Corp is a strong investment it is important to analyze Instadose Pharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Instadose Pharma's future performance. For an informed investment choice regarding Instadose Stock, refer to the following important reports:
Check out Instadose Pharma Correlation with its peers.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Will Pharmaceuticals sector continue expanding? Could Instadose diversify its offerings? Factors like these will boost the valuation of Instadose Pharma. Market participants price Instadose higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Instadose Pharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Return On Assets
(694.06)
Investors evaluate Instadose Pharma Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Instadose Pharma's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Instadose Pharma's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Instadose Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instadose Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Instadose Pharma's market price signifies the transaction level at which participants voluntarily complete trades.